Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia

By Alonci A.  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1336-1339

Humana Press, Inc

Access to resources Recommend Favorite

Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia

By Cha Zhanshan   Zang Yan   Guo Huijun   Rechlic James   Olasnova Lindsay   Gu Haihui   Tu Xiaohua   Song Haihan   Qian Baohua  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3579-3585

Springer Publishing Company

Access to resources Recommend Favorite

Key Issues in the Treatment of Chronic Lymphocytic Leukaemia (CLL)

By Catovsky D.   Murphy R.L.W.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2146-2154

Elsevier

Access to resources Recommend Favorite

Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

By Adair Sara   Hogan Kevin  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 589-601

Springer Publishing Company

Access to resources Recommend Favorite

Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): Comparison of indolent and progressive disease

By Kiaii Shahryar   Choudhury Aniruddha   Mozaffari Fariba   Kimby Eva   Österborg Anders   Mellstedt Håkan  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 291-302

Humana Press, Inc

Access to resources Recommend Favorite